Drug-Resistant Malaria - libdoc.who.int - World Health Organization

More documents

Recommendations

Info

18 / REVIEW . -Resis tant . Distribut1~n . arum of Chloro~u1ne in AS1a a~981. d Australas1a. Plasmo dium Status falc1p on 31 December , . • Q' 'It. -' . .... ~.
Distribution of Chloroquine-<strong>Resistant</strong> Plasmodium falciparum in South America. Status on 31 December 1981. REVIEW / 19
Page 1: Drug-Resistant Malaria The Report o
Page 5: Foreword A meeting on drug-resistan
Page 8 and 9: CONTENTS Page Drug Pressure and Res
Page 10 and 11: 2 / INTRODUCTION Differences in dru
Page 13 and 14: II. Opening Address and Messages Ol
Page 15 and 16: OPENING ADDRESS / 7 phical boundari
Page 17 and 18: OPENING ADDRESS / 9 to preserve for
Page 19 and 20: OPENING ADDRESS / 11 is also here a
Page 21 and 22: Ill. Review of Drug Resistance in P
Page 23 and 24: REVIEW I 15 Table 1. Sensitivity Te
Page 25: REVIEW / 17 Other Studies Validatio
Page 29 and 30: REVIEW I 21 are signs to suggest th
Page 31 and 32: REVIEW / 23 (h) specialized investi
Page 33 and 34: REVIEW / 25 TABLE 3~ Comparison of
Page 35 and 36: REVIEW / 27 Of 22 mefloquine in vit
Page 37 and 38: REVIEW / 29 operational conditions
Page 39 and 40: REVIEW / 31 the possible influence
Page 41 and 42: IV. Monitoring of Drug Response of
Page 43 and 44: MONITORING / 35 during recent years
Page 45 and 46: MONITORING / 37 India, Sri Lanka an
Page 47 and 48: Table 4. Results of Micro In Vitro
Page 49 and 50: MONITORING / 41 The superiority of
Page 51 and 52: MONITORING / 43 input of the result
Page 53 and 54: MONITORING / 45 table time 1ag and
Page 55 and 56: Table 6. Probability of Detecting t
Page 57 and 58: MONITORING / 49 prevalence = 10% an
Page 59: MONITORING / 51 TDR. At the end of
Page 62 and 63: 54 / RESEARCH RESULTS characteristi
Page 64 and 65: 56 / RESEARCH RESULTS EXO-ERYTHROCY
Page 67 and 68: VI. Control of Drug-Resistant P. fa
Page 69 and 70: CONTROL / 61 DRUG USE AIMING AT PRE
Page 71 and 72: Table 7. Specific Actions for the C
Page 73 and 74: CONTROL / 65 Table 8. Drugs or Comb
Page 75 and 76: Table 9. Suggested Use of Antimalar
Page 77 and 78:
Table 9. Suggested Use of Antimalar
Page 79 and 80:
CONTROL / 71 Radical therapy of mic
Page 81 and 82:
CONTROL / 73 Tanzania several years
Page 83 and 84:
VII. Field and Laboratory Research
Page 85 and 86:
RESEARCH FOR CONTROL / 77 In vivo a
Page 87 and 88:
RESEARCH FOR CONTROL / 79 migrants
Page 89 and 90:
RESEARCH FOR CONTROL / 81 and Phase
Page 91:
RESEARCH FOR CONTROL / 83 (b) Metho
Page 94 and 95:
86 / RECOMMENDATIONS and sulfonamid
Page 96 and 97:
88 / RECOMMENDATIONS (xiii) Simple
Page 99 and 100:
IX. Summary The Meeting on Drug-Res
Page 101 and 102:
APPENDIX 1 List of Participants, Ob
Page 103 and 104:
APPENDICES / 95 Sri Lanka Dr M.K. B
Page 105 and 106:
APPENDICES / 97 Papua New Guinea Dr
Page 107 and 108:
APPENDICES / 99 TEMPORARY ADVISERS
Page 109 and 110:
APPENDICES / 101 Dr L.E. Molineaux
Page 111 and 112:
APPENDIX 2 List of Documents A. WOR
Page 113 and 114:
APPENDICES / 105 Comparative study
Page 115 and 116:
APPENDIX 3.1 I 107 RESPONSE OF Plas
Page 117:
APPENDIX 3.2 / 109 RESPONSE OF P. F
Page 120 and 121:
112 / APPENDICES 0.25 0.50 0.75 1.0
Page 122 and 123:
114 / APPENDICES Chloroquine is eff
Page 124 and 125:
116 / APPENDICES 1.4 Sulfonamide pl
Page 126 and 127:
118 / Various tetracycline analogs
Page 128 and 129:
120 / APPENDICES A loading dose on
Page 130 and 131:
122 / APPENDICES The drug should be
Page 132 and 133:
124 / APPEND ICE S 2. INDICATIONS f
Page 134 and 135:
126 / APPENDICES they are already r
Page 136 and 137:
128 / APPENDICES 5.2 In suppressive
Page 138 and 139:
130 / APPENDICES Outline research p
Page 140 and 141:
132 / APPENDICES Long-term To preve
Page 143 and 144:
APPENDIX 8 Considerations Related t
Page 145 and 146:
APPENDICES / 137 4. Screening point
show all

Drug-Resistant Malaria - libdoc.who.int - World Health Organization

Create successful ePaper yourself

Delete template?

Save as template?